O. 'brien, D. P. Comte, E. Serafini, M. Ehounou, G. Antierens et al., The urgent need for clinical, diagnostic, and operational research for management of buruli ulcer in africa, Lancet Infect. Dis. World Health Organization, vol.2014, issue.14 2, pp.435-440, 2012.

R. R. Yotsu, C. Murase, M. Sugawara, K. Suzuki, K. Nakanaga et al., Revisiting Buruli ulcer, The Journal of Dermatology, vol.66, issue.11, pp.1033-1041, 2015.
DOI : 10.1128/AEM.66.8.3206-3213.2000
URL : http://onlinelibrary.wiley.com/doi/10.1111/1346-8138.13049/pdf

B. Carbonnelle, Aquatic insects as a vector for Mycobacterium ulcerans, Appl. Environ. Microbiol, vol.68, pp.4623-4628, 2002.

D. Pluot-sigwalt, Molecular species delimitation and morphology of aquatic and sub-aquatic bugs (Heteroptera) in cameroon, PLoS ONE, vol.11, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01333894

K. M. George, D. Chatterjee, G. Gunawardana, D. Welty, J. Hayman et al., Mycolactone: A polyketide toxin from Mycobacterium ulcerans required for virulence ulcer: Reductive evolution enhances pathogenicity of Mycobacterium ulcerans, Science Nat. Rev. Microbiol, vol.283, issue.7, pp.854-857, 1999.

F. S. Sarfo, R. Phillips, M. Wansbrough-jones, and R. E. Simmonds, infection/Buruli ulcer disease, Cellular Microbiology, vol.1808, issue.Suppl, pp.17-29, 2016.
DOI : 10.1016/j.bbamem.2010.06.015
URL : https://hal.archives-ouvertes.fr/pasteur-01402286

N. Clere and V. Paille, Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways, Cell, vol.2014, issue.157, pp.1565-1576
URL : https://hal.archives-ouvertes.fr/hal-01117565

S. Benitez, A. Seltzer, and C. Acosta, Nociceptor-like rat dorsal root ganglion neurons express the angiotensin-II AT2 receptor throughout development, International Journal of Developmental Neuroscience, vol.56, issue.56, pp.10-17
DOI : 10.1016/j.ijdevneu.2016.11.001

L. Yu, C. Shao, and L. Gao, Developmental expression patterns for angiotensin receptors in mouse skin and brain, Journal of the Renin-Angiotensin-Aldosterone System, vol.244, issue.2, pp.139-149, 2012.
DOI : 10.1126/science.2734613

U. Anand, P. Facer, Y. Yiangou, M. Sinisi, M. Fox et al., R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons, European Journal of Pain, vol.93, issue.21, pp.1012-1026, 2013.
DOI : 10.1073/pnas.93.21.11968

J. N. Wood, Results in Analgesia ??? Darwin 1, Pharma 0, New England Journal of Medicine, vol.369, issue.26, pp.2558-2560
DOI : 10.1056/NEJMcibr1313354

M. Willenborg, M. Belz, K. Schumacher, A. Paufler, and K. Hatlapatka, Ca2+-dependent desensitization of insulin secretion by strong potassium depolarization, AJP: Endocrinology and Metabolism, vol.303, issue.2, pp.223-233, 2012.
DOI : 10.1152/ajpendo.00010.2012

A. Cadaveira-mosquera, S. J. Ribeiro, A. Reboreda, M. Perez, and J. A. Lamas, Activation of TREK Currents by the Neuroprotective Agent Riluzole in Mouse Sympathetic Neurons, Journal of Neuroscience, vol.31, issue.4, pp.31-1375, 2011.
DOI : 10.1523/JNEUROSCI.2791-10.2011

Y. Xing, Y. Zhang, C. R. Stabernack, E. I. Eger, and A. Gray, The Use of the Potassium Channel Activator Riluzole to Test Whether Potassium Channels Mediate the Capacity of Isoflurane to Produce Immobility, Anesthesia & Analgesia, vol.97, pp.1020-1024, 2003.
DOI : 10.1213/01.ANE.0000077073.92108.E7

F. S. Sguilla, A. C. Tedesco, and L. M. Bendhack, A membrane potential-sensitive dye for vascular smooth muscle cells assays, Biochemical and Biophysical Research Communications, vol.301, issue.1, pp.113-118, 2003.
DOI : 10.1016/S0006-291X(02)02973-X

D. Bartolo, V. Demangel, and C. , Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events, J. Immunol, vol.184, pp.1436-1444, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00594632

S. Adusumilli, A. Mve-obiang, T. Sparer, W. Meyers, J. Hayman et al., Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo, Cellular Microbiology, vol.1, issue.Suppl., pp.1295-1304, 2005.
DOI : 10.1093/infdis/157.3.577

R. Bieri, N. Scherr, M. T. Ruf, J. P. Dangy, P. Gersbach et al., The Macrolide Toxin Mycolactone Promotes Bim-Dependent Apoptosis in Buruli Ulcer through Inhibition of mTOR, ACS Chemical Biology, vol.12, issue.5, pp.1297-1307, 2017.
DOI : 10.1021/acschembio.7b00053

J. P. Dangy, N. Scherr, P. Gersbach, M. N. Hug, R. Bieri et al., Antibody-Mediated Neutralization of the Exotoxin Mycolactone, the Main Virulence Factor Produced by Mycobacterium ulcerans, PLOS Neglected Tropical Diseases, vol.189, issue.5, p.4808, 2016.
DOI : 10.1371/journal.pntd.0004808.s001

C. Bozzo, R. Tiberio, F. Graziola, G. Pertusi, G. Valente et al., A Mycobacterium ulcerans toxin, mycolactone, induces apoptosis in primary human keratinocytes and in HaCaT cells, Microbes and Infection, vol.12, issue.14-15, pp.1258-1263, 2010.
DOI : 10.1016/j.micinf.2010.08.005

A. Gronberg, L. Zettergren, K. Bergh, M. Stahle, J. Heilborn et al., Antioxidants Protect Keratinocytes against M. ulcerans Mycolactone Cytotoxicity, PLoS ONE, vol.7, issue.11, p.13839, 2010.
DOI : 10.1371/journal.pone.0013839.g003

J. Ogbechi, M. T. Ruf, B. S. Hall, K. Bodman-smith, M. Vogel et al., Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions, PLOS Pathogens, vol.125, issue.Suppl 1, 2015.
DOI : 10.1371/journal.ppat.1005011.s005

E. Coutanceau, J. Decalf, A. Martino, A. Babon, N. Winter et al., toxin mycolactone, The Journal of Experimental Medicine, vol.22, issue.6, pp.1395-1403, 2007.
DOI : 10.1016/0022-1759(94)90236-4
URL : https://hal.archives-ouvertes.fr/pasteur-01402321

U. Anand, M. Sinisi, M. Fox, A. Macquillan, T. Quick et al., Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons, Molecular Pain, vol.16, pp.1-11, 2016.
DOI : 10.1093/brain/121.12.2239
URL : http://doi.org/10.1177/1744806916654144

Y. Wan, C. Wallinder, B. Plouffe, H. Beaudry, A. K. Mahalingam et al., Receptor Agonist, Journal of Medicinal Chemistry, vol.47, issue.24, pp.5995-6008, 2004.
DOI : 10.1021/jm049715t

A. Danckaert, M. T. Ruf, S. Mostowy, and C. Zurzolo, Mycolactone activation of wiskott-aldrich syndrome proteins underpins buruli ulcer formation, J. Clin. Investig, vol.123, pp.1501-1512, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-00874628

B. S. Hall, K. Hill, M. Mckenna, J. Ogbechi, S. High et al., The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER, PLoS Pathogens, vol.103, issue.4, p.1004061, 2014.
DOI : 10.1371/journal.ppat.1004061.s004

L. Baron, A. O. Paatero, J. D. Morel, F. Impens, L. Guenin-mace et al., Mycolactone subverts immunity by selectively blocking the Sec61 translocon, The Journal of Experimental Medicine, vol.213, issue.13, pp.2885-2896, 2016.
DOI : 10.1016/S0076-6879(83)96010-X
URL : https://hal.archives-ouvertes.fr/pasteur-01432024

F. S. Sarfo, F. Le-chevalier, N. Aka, R. O. Phillips, Y. Amoako et al., Mycolactone Diffuses into the Peripheral Blood of Buruli Ulcer Patients - Implications for Diagnosis and Disease Monitoring, PLoS Neglected Tropical Diseases, vol.9, issue.7, pp.5-1237, 2011.
DOI : 10.1371/journal.pntd.0001237.t001
URL : https://hal.archives-ouvertes.fr/inserm-00691438

F. S. Sarfo, R. O. Phillips, J. Zhang, M. K. Abass, J. Abotsi et al., Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease, BMC Infectious Diseases, vol.123, issue.4, pp.14-202, 2014.
DOI : 10.1172/JCI66576

E. Marion, S. Prado, C. Cano, J. Babonneau, S. Ghamrawi et al., Photodegradation of the Mycobacterium ulcerans Toxin, Mycolactones: Considerations for Handling and Storage, PLoS ONE, vol.7, issue.4, p.33600, 2012.
DOI : 10.1371/journal.pone.0033600.s003

L. Marsollier, P. Brodin, M. Jackson, J. Kordulakova, P. Tafelmeyer et al., Impact of Mycobacterium ulcerans Biofilm on Transmissibility to Ecological Niches and Buruli Ulcer Pathogenesis, PLoS Pathogens, vol.63, issue.5, p.62, 2007.
DOI : 10.1371/journal.ppat.0030062.st001

M. T. Rudd and K. Hollenstein, Structural basis for selectivity and diversity in angiotensin II receptors, Nature, vol.2017, issue.544, pp.327-332

A. S. Yekkirala, D. P. Roberson, B. P. Bean, and C. J. Woolf, Breaking barriers to novel analgesic drug development, Nature Reviews Drug Discovery, vol.51, issue.8
DOI : 10.1007/s00726-012-1390-z

L. Hein, G. S. Barsh, R. E. Pratt, V. J. Dzau, and B. K. Kobilka, Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice, Nature, vol.377, issue.6551, pp.744-747, 1995.
DOI : 10.1038/377744a0

D. Fenistein, B. Lenseigne, T. Christophe, P. Brodin, and A. Genovesio, A fast, fully automated cell segmentation algorithm for high-throughput and high-content screening, Cytometry Part A, vol.30, issue.10, pp.958-964, 2008.
DOI : 10.1002/cyto.a.20627